Patient-Friendly Explanation

Thiazolidinediones, also called TZDs or glitazones, are tablets used to treat type 2 diabetes. They help the body use insulin better, but they often cause weight gain and swelling of the ankles and legs. People taking them may need extra help keeping their weight on track.

Clinical Definition

Thiazolidinediones, including pioglitazone and rosiglitazone, are PPAR-gamma agonists that improve insulin sensitivity in adipose tissue, skeletal muscle and liver. They also promote adipocyte differentiation and renal sodium and fluid retention, producing dose-related weight gain of roughly 1 to 4 kg and peripheral oedema, and they can precipitate or worsen heart failure in predisposed patients. Where weight control is a priority, alternatives with weight-neutral or weight-losing profiles such as metformin, SGLT2 inhibitors and GLP-1 receptor agonists may be preferred, though any change must be made with the prescribing clinician.

Why It Matters

Some diabetes medicines quietly work against a patient’s weight-loss efforts, which is frustrating when you are doing everything right. The team at NuLifeCare Singapore reviews your medication list during consultations and can coordinate with your prescribing doctor if a more weight-friendly option exists.